Digital Health Care is already fully utilized in the US, isn’t it?

Step into the future of healthcare with Dr. Stefan Walzer and Kate Claessens, on this podcast episode where we dissect the pulse of digital health in the USA. From public acceptance to intricate reimbursement pathways, and the potential shifts under the Biden administration, we’re covering the essentials you need to know. How does digital healthcare navigate the complex US reimbursement landscape? What strategic moves should you anticipate next?

Join us as we delve into these critical discussions, offering more expert insights with the practical experience of Anna Forsythe, a titan in global product commercialization and strategic drug development from Purple Squirrel Economics. Whether you’re eyeing the US market for your digital health solutions or simply keen on the latest in healthcare innovation, this episode is your roadmap to understanding and conquering one of the world’s most lucrative markets.

Listen to the podcast: here